Kim Caple, Vice President and General Manager Capillary Electrophoresis Platform, shares the idea behind the new Applied Biosystems SeqStudio Genetic Analyzer. Kim discusses how Sanger sequencing and fragment analysis has changed over the years, how the SeqStudio instrument fits within our portfolio of sequencers and a look into the various applications that are uniquely suited to Sanger sequencing and fragment analysis. Finally, Kim shares the vision for capillary electrophoresis technology. Watch the video below!
To learn more about the SeqStudio instrument or to watch the demo click here.
Be sure to catch our full live stream of the announcement here.